Showing results (461-470 of 644) with videos related to
Sort By:
Pageof 65
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 1, 2024
A quasi-experimental study of a bundled diagnostic stewardship intervention for ventilator-associated pneumoniaOwen R Albin, Jonathan P Troost, Louis Saravolatz, et al.Antimicrobial Agents and Chemotherapy|May 25, 2016
An Immunocompromised Child with Bloodstream Infection Caused by Two Escherichia coli Strains, One Harboring NDM-5 and the Other Harboring OXA-48-Like CarbapenemaseM Earth Hasassri, Thomas G Boyce, Andrew P Norgan, et al.Infection Control and Hospital Epidemiology|November 25, 2014
Prevalence of and risk factors for vancomycin-resistant Staphylococcus aureus precursor organisms in Southeastern MichiganValerie S Albrecht, Marcus J Zervos, Keith S Kaye, et al.Infection Control and Hospital Epidemiology|July 1, 2010
Observer bias in hand hygiene compliance reportingSorabh Dhar, Ryan Tansek, Elizabeth A Toftey, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancerJ Nemunaitis, F Khuri, I Ganly, et al.Antibiotics (Basel, Switzerland)|August 6, 2021
In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant Acinetobacter baumanniiJacinda C Abdul-Mutakabbir, Juwon Yim, Logan Nguyen, et al.Annals of Clinical Microbiology and Antimicrobials|June 5, 2015
Simple bedside score to optimize the time and the decision to initiate appropriate therapy for carbapenem-resistant EnterobacteriaceaeViolet Leibman, Emily T Martin, Ruthy Tal-Jasper, et al.American Journal of Epidemiology|February 19, 2005
Utility of the Chronic Disease Score and Charlson Comorbidity Index as comorbidity measures for use in epidemiologic studies of antibiotic-resistant organismsJessina C McGregor, Peter W Kim, Eli N Perencevich, et al.Antimicrobial Agents and Chemotherapy|December 19, 2025
A mechanism-based pharmacokinetic/pharmacodynamic analysis of polymyxin B-based combination therapy against carbapenem-resistant Klebsiella pneumoniae isolates with diverse phenotypic and genotypic resistance mechanismsRamya Mahadevan, Estefany Garcia, Rajnikant Sharma, et al.American Journal of Infection Control|May 3, 2015
Risk factors for bloodstream infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: A focus on antimicrobials including cefepimeTeena Chopra, Dror Marchaim, Paul C Johnson, et al.Pageof 65